These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 38232993)

  • 1. Development of a cross-sectoral antimicrobial resistance capability assessment framework.
    Ferdinand AS; McEwan C; Lin C; Betham K; Kandan K; Tamolsaian G; Pugeva B; McKenzie J; Browning G; Gilkerson J; Coppo M; James R; Peel T; Levy S; Townell N; Jenney A; Stewardson A; Cameron D; Macintyre A; Buising K; Howden BP
    BMJ Glob Health; 2024 Jan; 9(1):. PubMed ID: 38232993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The global governance of antimicrobial resistance: a cross-country study of alignment between the global action plan and national action plans.
    Munkholm L; Rubin O
    Global Health; 2020 Nov; 16(1):109. PubMed ID: 33176810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implementing national strategies on antimicrobial resistance in Thailand: potential challenges and solutions.
    Sommanustweechai A; Tangcharoensathien V; Malathum K; Sumpradit N; Kiatying-Angsulee N; Janejai N; Jaroenpoj S
    Public Health; 2018 Apr; 157():142-146. PubMed ID: 29524812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Building resilient and responsive research collaborations to tackle antimicrobial resistance-Lessons learnt from India, South Africa, and UK.
    Veepanattu P; Singh S; Mendelson M; Nampoothiri V; Edathadatil F; Surendran S; Bonaconsa C; Mbamalu O; Ahuja S; Birgand G; Tarrant C; Sevdalis N; Ahmad R; Castro-Sanchez E; Holmes A; Charani E
    Int J Infect Dis; 2020 Nov; 100():278-282. PubMed ID: 32860949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Setting up laboratory-based antimicrobial resistance surveillance in low- and middle-income countries: lessons learned from Georgia.
    Malania L; Wagenaar I; Karatuna O; Tambic Andrasevic A; Tsereteli D; Baidauri M; Imnadze P; Nahrgang S; Ruesen C
    Clin Microbiol Infect; 2021 Oct; 27(10):1409-1413. PubMed ID: 34044149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimicrobial resistance control efforts in Africa: a survey of the role of Civil Society Organisations.
    Fraser JL; Alimi YH; Varma JK; Muraya T; Kujinga T; Carter VK; Schultsz C; Del Rio Vilas VJ
    Glob Health Action; 2021 Jan; 14(1):1868055. PubMed ID: 33475046
    [No Abstract]   [Full Text] [Related]  

  • 7. Methodological Approach to Identify and Expand the Volume of Antimicrobial Resistance (AMR) Data in the Human Health Sector in Low- and Middle-Income Countries in Asia: Implications for Local and Regional AMR Surveillance Systems Strengthening.
    Joh HS; Yeats C; Shaw A; Poudyal N; Gallagher P; Kim JH; Shaikh A; Seo HJ; Chi KK; Prifti K; Cho A; Sujan MJ; Eraly E; Pham KD; Shrestha S; Aboushady AT; Pak G; Jang G; Park EL; Seo HW; Abudahab K; Taylor BEW; Clark A; Dolabella B; Yoon H; Han J; Kwon SY; Marks F; Stelling J; Aanensen DM; MacWright WR; Holm M
    Clin Infect Dis; 2023 Dec; 77(Suppl 7):S507-S518. PubMed ID: 38118007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Closing the GAP in Antimicrobial Resistance Policy in Benin and Burkina Faso.
    Sariola S; Butcher A; Cañada JA; Aïkpé M; Compaore A
    mSystems; 2022 Aug; 7(4):e0015022. PubMed ID: 35894597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Attention to the Tripartite's one health measures in national action plans on antimicrobial resistance.
    Munkholm L; Rubin O; Bækkeskov E; Humboldt-Dachroeden S
    J Public Health Policy; 2021 Jun; 42(2):236-248. PubMed ID: 33597731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coverage of policies to improve antimicrobial stewardship in human medicine in low and middle income countries: results from the Global Survey of Experts on Antimicrobial Resistance.
    Zay Ya K; Lambiris MJ; Levine GA; Tediosi F; Fink G
    BMC Public Health; 2024 Aug; 24(1):2297. PubMed ID: 39180027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparative assessment of action plans on antimicrobial resistance from OECD and G20 countries using natural language processing.
    Özçelik EA; Doucet C; Kang H; Levy N; Feldhaus I; Hashiguchi TCO; Lerouge A; Cecchini M
    Health Policy; 2022 Jun; 126(6):522-533. PubMed ID: 35379524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Burden of bacterial antimicrobial resistance in low-income and middle-income countries avertible by existing interventions: an evidence review and modelling analysis.
    Lewnard JA; Charani E; Gleason A; Hsu LY; Khan WA; Karkey A; Chandler CIR; Mashe T; Khan EA; Bulabula ANH; Donado-Godoy P; Laxminarayan R
    Lancet; 2024 Jun; 403(10442):2439-2454. PubMed ID: 38797180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Train-the-Trainer as an Effective Approach to Building Global Networks of Experts in Genomic Surveillance of Antimicrobial Resistance (AMR).
    Abrudan M; Matimba A; Nikolic D; Hughes D; Argimón S; Kekre M; Underwood A; Aanensen DM;
    Clin Infect Dis; 2021 Dec; 73(Suppl_4):S283-S289. PubMed ID: 34850831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An analysis of existing national action plans for antimicrobial resistance-gaps and opportunities in strategies optimising antibiotic use in human populations.
    Charani E; Mendelson M; Pallett SJC; Ahmad R; Mpundu M; Mbamalu O; Bonaconsa C; Nampoothiri V; Singh S; Peiffer-Smadja N; Anton-Vazquez V; Moore LSP; Schouten J; Kostyanev T; Vlahović-Palčevski V; Kofteridis D; Corrêa JS; Holmes AH
    Lancet Glob Health; 2023 Mar; 11(3):e466-e474. PubMed ID: 36739875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of the COVID-19 pandemic on the surveillance, prevention and control of antimicrobial resistance: a global survey.
    Tomczyk S; Taylor A; Brown A; de Kraker MEA; El-Saed A; Alshamrani M; Hendriksen RS; Jacob M; Löfmark S; Perovic O; Shetty N; Sievert D; Smith R; Stelling J; Thakur S; Vietor AC; Eckmanns T;
    J Antimicrob Chemother; 2021 Oct; 76(11):3045-3058. PubMed ID: 34473285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opportunities and challenges in antimicrobial resistance policy including animal production systems and humans across stakeholders in Argentina: a context and qualitative analysis.
    Allel K; Fernandez-Miyakawa M; Gaze W; Petroni A; Corso A; Luna F; Barcelona L; Boden L; Pitchforth E;
    BMJ Open; 2024 Jun; 14(6):e082156. PubMed ID: 38889938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A review of national action plans on antimicrobial resistance: strengths and weaknesses.
    Willemsen A; Reid S; Assefa Y
    Antimicrob Resist Infect Control; 2022 Jun; 11(1):90. PubMed ID: 35739564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implementation of the World Health Organization Global Antimicrobial Resistance Surveillance System in Uganda, 2015-2020: Mixed-Methods Study Using National Surveillance Data.
    Nabadda S; Kakooza F; Kiggundu R; Walwema R; Bazira J; Mayito J; Mugerwa I; Sekamatte M; Kambugu A; Lamorde M; Kajumbula H; Mwebasa H
    JMIR Public Health Surveill; 2021 Oct; 7(10):e29954. PubMed ID: 34673531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploring the factors that contribute to the successful implementation of antimicrobial resistance interventions: a comparison of high-income and low-middle-income countries.
    Graells T; Lambraki IA; Cousins M; Léger A; Henriksson PJG; Troell M; Carson CA; Parmley EJ; Majowicz SE; Wernli D; Jørgensen PS
    Front Public Health; 2023; 11():1230848. PubMed ID: 37900049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Supporting surveillance capacity for antimicrobial resistance: Laboratory capacity strengthening for drug resistant infections in low and middle income countries.
    Seale AC; Hutchison C; Fernandes S; Stoesser N; Kelly H; Lowe B; Turner P; Hanson K; Chandler CIR; Goodman C; Stabler RA; Scott JAG
    Wellcome Open Res; 2017; 2():91. PubMed ID: 29181453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.